Estimating the global cost of vision impairment and its major causes: protocol for a systematic review
Introduction Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic rev...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e036689.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555000402116608 |
|---|---|
| author | Nathan Congdon Thomas Butt Peng Tee Khaw Andrew Bastawrous Tasanee Braithwaite Rupert R A Bourne Matthew J Burton Serge Resnikoff Jacqueline Ramke Kevin Frick Hugh Taylor Iris Gordon Ana Patricia Marques John Cairns Justine H Zhang Hannah B Faal Iain Jones Marty Jovic Allyala Nandakumar |
| author_facet | Nathan Congdon Thomas Butt Peng Tee Khaw Andrew Bastawrous Tasanee Braithwaite Rupert R A Bourne Matthew J Burton Serge Resnikoff Jacqueline Ramke Kevin Frick Hugh Taylor Iris Gordon Ana Patricia Marques John Cairns Justine H Zhang Hannah B Faal Iain Jones Marty Jovic Allyala Nandakumar |
| author_sort | Nathan Congdon |
| collection | DOAJ |
| description | Introduction Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic review of the literature is needed. Here we outline the protocol for a systematic review to describe and summarise the costs associated with VI and its major causes.Methods and analysis We will systematically search in Medline (Ovid) and the Centre for Reviews and Dissemination database which includes the National Health Service Economics Evaluation Database. No language or geographical restriction will be applied. Additional literature will be identified by reviewing the references in the included studies and by contacting field experts. Grey literature will be considered. The review will include any study published from 1 January 2000 to November 2019 that provides information about costs of illness, burden of disease and/or loss of well-being in participants with VI due to an unspecified cause or due to one of the seven leading causes globally.Two reviewers will independently screen studies and extract relevant data from included studies. Methodological quality of economic studies will be assessed based on the British Medical Journal checklist for economic submissions adapted to costs of illness studies. This protocol has been prepared following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols and has been published prospectively in Open Science Framework.Ethics and dissemination Formal ethical approval is not required, as primary data will not be collected in this review. The findings of this study will be disseminated through peer-reviewed publications, stakeholder meetings and inclusion in the ongoing Lancet Global Health Commission on Global Eye Health.Registration details https://osf.io/9au3w (DOI 10.17605/OSF.IO/6F8VM). |
| format | Article |
| id | doaj-art-3d2d84f86fa94cc7845b0331f6a6576b |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-3d2d84f86fa94cc7845b0331f6a6576b2025-01-08T07:00:07ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2019-036689Estimating the global cost of vision impairment and its major causes: protocol for a systematic reviewNathan Congdon0Thomas Butt1Peng Tee Khaw2Andrew Bastawrous3Tasanee Braithwaite4Rupert R A Bourne5Matthew J Burton6Serge Resnikoff7Jacqueline Ramke8Kevin Frick9Hugh Taylor10Iris Gordon11Ana Patricia Marques12John Cairns13Justine H Zhang14Hannah B Faal15Iain Jones16Marty Jovic17Allyala Nandakumar18School of Medicine, Dentistry and Biomedical Sciences, Centre for Public Health, Queen`s University Belfast MDBS, Belfast, UKUCL Institute of Ophthalmology, University College London, London, UK1 University College London Institute of Ophthalmology, London, UKDepartment for Clinical Research, London School of Hygiene & Tropical Medicine, London, UKNeuro-ophthalmology, Moorfields Eye Hospital and The National Hospital for Neurology & Neurosurgery, London, UK1Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UKClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UKBrien Holden Vision Institute; School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, AustraliaSchool of Optometry & Vision Science, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New ZealandJohns Hopkins University Carey Business School - Baltimore Campus, Baltimore, Maryland, USAUniversity of Melbourne School of Population and Global Health, Melbourne, Victoria, AustraliaInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UKInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UKDepartment of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicin, London, UKInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, United KingdomDepartment of Ophthalmology, University of Calabar, Calabar, NigeriaSightsavers, Haywards Heath, UKPricewaterhouseCoopers, Sydney, New South Wales, AustraliaBrandeis University, Waltham, Massachusetts, USAIntroduction Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic review of the literature is needed. Here we outline the protocol for a systematic review to describe and summarise the costs associated with VI and its major causes.Methods and analysis We will systematically search in Medline (Ovid) and the Centre for Reviews and Dissemination database which includes the National Health Service Economics Evaluation Database. No language or geographical restriction will be applied. Additional literature will be identified by reviewing the references in the included studies and by contacting field experts. Grey literature will be considered. The review will include any study published from 1 January 2000 to November 2019 that provides information about costs of illness, burden of disease and/or loss of well-being in participants with VI due to an unspecified cause or due to one of the seven leading causes globally.Two reviewers will independently screen studies and extract relevant data from included studies. Methodological quality of economic studies will be assessed based on the British Medical Journal checklist for economic submissions adapted to costs of illness studies. This protocol has been prepared following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols and has been published prospectively in Open Science Framework.Ethics and dissemination Formal ethical approval is not required, as primary data will not be collected in this review. The findings of this study will be disseminated through peer-reviewed publications, stakeholder meetings and inclusion in the ongoing Lancet Global Health Commission on Global Eye Health.Registration details https://osf.io/9au3w (DOI 10.17605/OSF.IO/6F8VM).https://bmjopen.bmj.com/content/10/9/e036689.full |
| spellingShingle | Nathan Congdon Thomas Butt Peng Tee Khaw Andrew Bastawrous Tasanee Braithwaite Rupert R A Bourne Matthew J Burton Serge Resnikoff Jacqueline Ramke Kevin Frick Hugh Taylor Iris Gordon Ana Patricia Marques John Cairns Justine H Zhang Hannah B Faal Iain Jones Marty Jovic Allyala Nandakumar Estimating the global cost of vision impairment and its major causes: protocol for a systematic review BMJ Open |
| title | Estimating the global cost of vision impairment and its major causes: protocol for a systematic review |
| title_full | Estimating the global cost of vision impairment and its major causes: protocol for a systematic review |
| title_fullStr | Estimating the global cost of vision impairment and its major causes: protocol for a systematic review |
| title_full_unstemmed | Estimating the global cost of vision impairment and its major causes: protocol for a systematic review |
| title_short | Estimating the global cost of vision impairment and its major causes: protocol for a systematic review |
| title_sort | estimating the global cost of vision impairment and its major causes protocol for a systematic review |
| url | https://bmjopen.bmj.com/content/10/9/e036689.full |
| work_keys_str_mv | AT nathancongdon estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT thomasbutt estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT pengteekhaw estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT andrewbastawrous estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT tasaneebraithwaite estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT rupertrabourne estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT matthewjburton estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT sergeresnikoff estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT jacquelineramke estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT kevinfrick estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT hughtaylor estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT irisgordon estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT anapatriciamarques estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT johncairns estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT justinehzhang estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT hannahbfaal estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT iainjones estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT martyjovic estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview AT allyalanandakumar estimatingtheglobalcostofvisionimpairmentanditsmajorcausesprotocolforasystematicreview |